0R15 9365.0 -9.3856% 0R1E 8280.0 -2.4275% 0M69 None None% 0R2V 215.15 9769.2661% 0QYR 1210.5 -2.379% 0QYP 422.74 -2.1435% 0RUK None None% 0RYA 1178.0 -12.7407% 0RIH 173.9 -4.9986% 0RIH 169.25 -2.674% 0R1O 179.16 9379.3651% 0R1O None None% 0QFP None None% 0M2Z 290.0046 -0.2564% 0VSO None None% 0R1I None None% 0QZI 468.0 -5.1672% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 146.96 -5.7884%

Health Catalyst Inc

Healthcare US HCAT

7.9499USD
0.33(4.33%)

Last update at 2024-07-25T16:51:00Z

Day Range

7.467.96
LowHigh

52 Week Range

5.4514.37
LowHigh

Fundamentals

  • Previous Close 7.62
  • Market Cap403.21M
  • Volume211586
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-51.17600M
  • Revenue TTM296.79M
  • Revenue Per Share TTM5.19
  • Gross Profit TTM 135.56M
  • Diluted EPS TTM-1.87

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -141.68300M -160.10800M -116.21100M -59.95400M -62.11900M
Minority interest - - - - 0.00000M
Net income -137.40300M -153.21000M -115.01700M -60.09600M -61.98400M
Selling general administrative 61.70M 85.93M 59.24M 31.71M 22.69M
Selling and marketing expenses 87.51M 75.03M 55.41M 47.28M 44.12M
Gross profit 133.19M 117.57M 90.77M 79.60M 52.72M
Reconciled depreciation 48.30M 37.53M 18.73M 9.21M 7.41M
Ebit -140.00500M -143.65000M -96.12500M -54.86500M -59.53200M
Ebitda -91.70800M -106.12200M -77.40000M -45.65300M -52.12000M
Depreciation and amortization 48.30M 37.53M 18.73M 9.21M 7.41M
Non operating income net other - - -8.51400M - 0.00000M
Operating income -140.00500M -143.65000M -96.12500M -54.86500M -60.09500M
Other operating expenses 416.24M 385.58M 284.97M 209.81M 172.67M
Interest expense 1.68M 16.46M 11.57M 3.42M 2.59M
Tax provision -4.28000M -6.89800M -1.19400M 0.14M -0.13500M
Interest income 5.69M 0.83M 2.09M 2.81M 0.60M
Net interest income -1.55200M -16.48200M -11.62200M -3.45100M -1.98500M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense -4.28000M -6.89800M -1.19400M 0.14M -0.13500M
Total revenue 276.24M 241.93M 188.84M 154.94M 112.57M
Total operating expenses 273.19M 261.22M 186.89M 134.46M 112.82M
Cost of revenue 143.05M 124.35M 98.08M 75.34M 59.85M
Total other income expense net -1.67800M -16.45800M -20.08600M -5.08900M -0.03900M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -137.40300M -153.21000M -115.01700M -60.09600M -61.98400M
Net income applicable to common shares -137.40300M -153.21000M -115.01700M -240.92200M -114.02100M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 701.81M 752.29M 832.10M 577.74M 302.36M
Intangible assets 73.38M 92.19M 104.79M 98.92M 25.54M
Earning assets - - - - -
Other current assets 12.28M 16.34M 14.61M 10.63M 8.39M
Total liab 334.89M 327.28M 310.00M 301.64M 101.72M
Total stockholder equity 366.92M 425.01M 522.10M 276.10M 200.64M
Deferred long term liab - 2.60M 3.00M 1.40M -
Other current liab 23.28M 19.69M 28.30M 32.94M 11.14M
Common stock 1484.06M 1424.68M 0.05M 0.04M 0.04M
Capital stock 1484.06M 1424.68M 0.05M 0.04M 0.04M
Retained earnings -1117.17000M -999.02300M -878.86000M -725.65000M -610.51400M
Other liab - 0.23M 15.76M 20.94M 3.65M
Good will 190.65M 185.98M 169.97M 107.82M 3.69M
Other assets 0.00000M 3.73M 4.50M 28.34M 0.81M
Cash 106.28M 116.31M 193.23M 91.95M 18.03M
Cash and equivalents - - - - -
Total current liabilities 89.03M 82.51M 93.05M 88.04M 48.22M
Current deferred revenue 55.75M 54.96M 56.63M 47.15M 30.65M
Net debt 142.79M 131.66M 11.38M 103.33M 34.63M
Short term debt 3.36M 3.43M 3.42M 2.62M 2.81M
Short long term debt - - - - -
Short long term debt total 249.07M 247.97M 204.61M 195.28M 52.66M
Other stockholder equity - -0.64800M 1400.97M 1001.64M 508.69M
Property plant equipment - 42.59M 44.45M 12.86M 8.08M
Total current assets 391.20M 427.80M 508.39M 329.80M 264.24M
Long term investments - - - - -
Net tangible assets - 146.84M 247.34M 69.36M 171.41M
Short term investments 211.45M 247.18M 251.75M 178.92M 210.25M
Net receivables 61.19M 47.97M 48.80M 48.30M 27.57M
Long term debt 228.03M 226.52M 180.94M 168.99M 48.20M
Inventory 0.00000M - - - -
Accounts payable 6.64M 4.42M 4.69M 5.33M 3.62M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.03M -0.64800M -0.06700M 0.06M 0.07M
Additional paid in capital - - - - -
Common stock total equity - - 0.05M 0.04M 0.04M
Preferred stock total equity - - - - -
Retained earnings total equity - - -878.86000M -725.65000M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6.94M 3.73M 4.50M 3.61M 0.81M
Deferred long term asset charges - - - - -
Non current assets total 310.62M 324.49M 323.70M 247.94M 38.12M
Capital lease obligations 21.03M 21.45M 23.67M 26.29M 4.46M
Long term debt total - - - - 48.20M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -39.02100M -74.47000M 29.54M -205.33000M 23.88M
Change to liabilities -10.69900M 12.84M 8.24M -0.00900M 14.90M
Total cashflows from investing activities -39.02100M -139.67800M -82.56500M -209.60200M 21.40M
Net borrowings - - 143.70M 25.35M 9.95M
Total cash from financing activities -2.61300M 264.08M 182.61M 231.38M 24.35M
Change to operating activities -3.99600M -8.32500M -7.08100M -4.84400M -4.36700M
Net income -137.40300M -153.21000M -115.01700M -60.09600M -61.98400M
Change in cash -76.91500M 101.27M 73.92M -10.39900M 5.45M
Begin period cash flow 193.23M 91.95M 18.03M 28.43M 22.98M
End period cash flow 116.31M 193.23M 91.95M 18.03M 28.43M
Total cash from operating activities -35.27000M -23.12300M -26.14800M -32.18400M -40.29600M
Issuance of capital stock 0.00000M 245.18M 0.00000M 206.72M 33.99M
Depreciation 48.30M 37.53M 18.73M 9.21M 7.41M
Other cashflows from investing activities - -54.75800M -104.33300M -205.26800M 23.91M
Dividends paid - - - - 0.00000M
Change to inventory - -8.32500M -7.08100M -3.65300M 2.46M
Change to account receivables 0.79M 0.10M -16.44800M 0.13M -3.62700M
Sale purchase of stock -8.39300M 270.37M 40.54M 0.00000M -8.71200M
Other cashflows from financing activities 1.81M 18.90M 239.65M 58.55M 33.06M
Change to netincome 66.24M 76.00M 60.15M 22.34M 7.19M
Capital expenditures 17.41M 18.47M 10.46M 4.33M 2.50M
Change receivables - 0.10M -16.44800M - 0.00000M
Cash flows other operating - -4.44100M 8.80M - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - 101.28M 73.90M - 0.00000M
Change in working capital -13.90700M 4.62M -3.82700M -1.26600M 9.75M
Stock based compensation 72.10M 65.14M 37.96M 17.84M 4.20M
Other non cash items 0.16M 29.93M 37.29M 2.08M 0.53M
Free cash flow -52.68400M -41.59000M -36.61300M -36.51800M -42.79900M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HCAT
Health Catalyst Inc
0.33 4.33% 7.95 - 19.01 1.21 0.97 0.97 -4.2091
GEHC
GE HealthCare Technologies Inc.
1.08 1.36% 80.77 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A
5.39 2.93% 189.64 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 9.07 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
0.10 2.10% 4.86 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Health Catalyst Inc

10897 South River Front Parkway, South Jordan, UT, United States, 84095

Key Executives

Name Title Year Born
Mr. Daniel D. Burton CEO & Director 1975
Mr. Bryan Truman Hunt Chief Financial Officer 1987
Mr. Paul Horstmeier Chief Operating Officer 1961
Mr. Daniel H. Orenstein Gen. Counsel & Sec. 1970
Mr. J. Patrick Nelli Jr. Sr. Advisor NA
Mr. Jason Alger Chief Accounting Officer 1984
Mr. Dave Ross Chief Technology Officer NA
Mr. Jason Jones Chief Analytics & Data Science Officer and GM of Data & Analytics Platform NA
Mr. Adam Brown Sr. VP of Investor Relations and Financial Planning & Analysis NA
Mr. Kyle J. Salyers Sr. VP of Corp. Devel. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions